News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Boxer Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/25/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 34,846 shares
@ $14.19, valued at
$494.5k
Sold 95,516 shares
@ $15.63, valued at
$1.5M
Sold 219,638 shares
@ $16.87, valued at
$3.7M
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
SC 13D/A
| Boxer Capital, LLC reports a 15.9% stake in Mirati Therapeutics, Inc. |
| 08/15/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Bought 57,533 shares
@ $27.8, valued at
$1.6M
Bought 1,201,440 shares
@ $27.8, valued at
$33.4M
|
|
| 08/15/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Bought 57,533 shares
@ $27.8, valued at
$1.6M
Bought 1,201,440 shares
@ $27.8, valued at
$33.4M
|
|
| 08/15/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Bought 475,000 shares
@ $5.15, valued at
$2.4M
Bought 2,340,579 options to buy
@ $5.1499, valued at
$12.1M
|
|
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/24/2023 |
4
| Boxer Capital, LLC (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Sold 995,000 shares
@ $1.25, valued at
$1.2M
|
|
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 2% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 4.6% stake in IDEAYA, Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 6.9% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/13/2022 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Bought 117,000 shares
@ $4.2539, valued at
$497.7k
Bought 50,000 shares
@ $4.4328, valued at
$221.6k
Bought 70,000 shares
@ $4.6461, valued at
$325.2k
|
|
| 10/06/2022 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Bought 25,606 shares
@ $3.6701, valued at
$94k
Bought 45,500 shares
@ $3.9262, valued at
$178.6k
Bought 40,500 shares
@ $3.8373, valued at
$155.4k
Bought 70,394 shares
@ $4.0638, valued at
$286.1k
|
|
| 09/19/2022 |
SC 13G
| Boxer Capital, LLC reports a 5.7% stake in SpringWorks Therapeutics, Inc. |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/15/2022 |
SC 13D/A
| Boxer Capital, LLC reports a 15.1% stake in Tyra Biosciences, Inc. |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/18/2022 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 575,201 shares
@ $35.25, valued at
$20.3M
|
|
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 7.5% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 7.2% stake in Atreca, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in MATINAS BIOPHARMA HOLDINGS, INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC has filed a Schedule 13D for Mereo Biopharma Group plc |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.7% stake in SOLID BIOSCIENCES INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 1.9% stake in Cabaletta Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 1.9% stake in DBV Technologies S.A. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in SILVERBACK THERAPEUTICS, INC. |
|
|
|